First Tracks Biotherapeutics Inc. (TRAX)
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 30.59 0.00%
TRAX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.09B
- EPS (TTM)
- -$4.71
- Dividend yield
- None
- 52-week range
- 14.72 – 49.91
- Day range
- 30.53 – 31.75
- Volume / Avg
- 349.28K / 788.93K
- Beta
- —
- Shares outstanding
- 35.73M
- Next earnings
- Nov 5, 2026
52-week range
TRAX stock today
On Oct 7, TRAX ended the session at $30.59, shedding $0.80 (2.55%), versus the S&P 500's 0.22% decline. Trading was light, with 349.28K shares changing hands, about 44% of the average daily volume. Shares are 38.7% below their 52-week high of $49.91 and 107.8% above the 52-week low of $14.72, in the middle of the past year's range.
First Tracks Biotherapeutics has posted a net loss over the last twelve months (EPS of -$4.71), so its P/E ratio is not meaningful. First Tracks Biotherapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About First Tracks Biotherapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 5, 2026
First Tracks Biotherapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVLNAvalyn Pharma Inc. | 25.53 | +0.39% | $1.13B | vs TRAX |
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs TRAX |
| LBRXLB Pharmaceuticals Inc | 34.16 | -0.29% | $1.10B | vs TRAX |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs TRAX |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs TRAX |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs TRAX |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs TRAX |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs TRAX |
Indexes, lists and sector
Largest Health Care stocks
First Tracks Biotherapeutics stock FAQ
What is First Tracks Biotherapeutics's stock price today?
TRAX last traded at $30.59 as of Oct 7, 4:00 PM EDT, down 2.55% on the day. Prices are delayed at least 15 minutes.
When is First Tracks Biotherapeutics's next earnings date?
First Tracks Biotherapeutics is expected to report earnings on Thursday, November 5, 2026.
What is the TRAX 52-week high?
The 52-week high for TRAX is $49.91 and the 52-week low is $14.72. The stock is currently 38.7% below its high.